Cargando…
Roll out of intraveneous artesunate under named patient programmes in the Netherlands, Belgium and France
BACKGROUND: Intravenous (IV) artesunate is the treatment of choice for severe malaria. In Europe, this treatment is only available in a few countries via named patient programmes (NPPs). As a case study, the legal and organisational aspects and pharmacovigilance of these NPPs and possibilities for h...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848968/ https://www.ncbi.nlm.nih.gov/pubmed/24063858 http://dx.doi.org/10.1186/1750-1172-8-150 |